Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


20.11.2017

1 Acta Neuropathol
1 Cancer
3 Clin Cancer Res
1 Eur J Cancer
2 J Clin Oncol
14 J Neurooncol
2 J Neuropathol Exp Neurol
1 J Neurosurg
2 Neuro Oncol
1 Neuroradiology
1 Pediatr Neurosurg
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. BOGEAS A, Morvan-Dubois G, El-Habr EA, Lejeune FX, et al
    Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Acta Neuropathol. 2017 Nov 17. doi: 10.1007/s00401-017-1783.
    PubMed     Text format     Abstract available


    Cancer

  2. RYDZEWSKI NR, Lesniak MS, Chandler JP, Kalapurakal JA, et al
    Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31088.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. CHEN Q, Cai J, Wang Q, Wang Y, et al
    Long non-coding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/beta-Catenin pathway by scaffolding EZH2.
    Clin Cancer Res. 2017 Nov 14. pii: clincanres.0605.2017.
    PubMed     Text format     Abstract available

  4. WICK W, Kessler T
    Drug repositioning meets precision in glioblastoma.
    Clin Cancer Res. 2017 Nov 13. pii: clincanres.2989.2017.
    PubMed     Text format     Abstract available

  5. NANDHU MS, Behera P, Bhaskaran V, Longo SL, et al
    Development of a function-blocking antibody against fibulin-3 as targeted reagent for glioblastoma.
    Clin Cancer Res. 2017 Nov 16. pii: clincanres.1628.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  6. LORIOT Y, Pagliaro L, Flechon A, Mardiak J, et al
    Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
    Eur J Cancer. 2017;87:140-146.
    PubMed     Text format     Abstract available


    J Clin Oncol

  7. JONES DTW, Witt O, Pfister SM
    BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma.
    J Clin Oncol. 2017 Nov 15:JCO2017758987. doi: 10.1200/JCO.2017.75.8987.
    PubMed     Text format    

  8. WANG X, Sun CL, Hageman L, Smith K, et al
    Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.
    J Clin Oncol. 2017;35:3688-3696.
    PubMed     Text format     Abstract available


    J Neurooncol

  9. YUSUF MB, Amsbaugh MJ, Burton E, Nelson M, et al
    Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2679.
    PubMed     Text format     Abstract available

  10. TAO X, Wang K, Dong J, Hou Z, et al
    Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2671.
    PubMed     Text format     Abstract available

  11. LAM SHIN CHEUNG V, Kim A, Sahgal A, Das S, et al
    Meningioma recurrence rates following treatment: a systematic analysis.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2659.
    PubMed     Text format     Abstract available

  12. FRIED I, Lossos A, Ben Ami T, Dvir R, et al
    Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2643.
    PubMed     Text format     Abstract available

  13. SAGE W, Guilfoyle M, Luney C, Young A, et al
    Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    J Neurooncol. 2017 Nov 14. doi: 10.1007/s11060-017-2649.
    PubMed     Text format     Abstract available

  14. IZQUIERDO C, Alentorn A, Idbaih A, Simo M, et al
    Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2677.
    PubMed     Text format     Abstract available

  15. NAGASHIMA H, Sasayama T, Tanaka K, Kyotani K, et al
    Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2655.
    PubMed     Text format     Abstract available

  16. ALBATANY M, Li A, Meakin S, Bartha R, et al
    Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2664.
    PubMed     Text format     Abstract available

  17. XU G, Li JY
    CK4, CK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
    J Neurooncol. 2017 Nov 17. doi: 10.1007/s11060-017-2674.
    PubMed     Text format     Abstract available

  18. TONSE R, Gupta T, Epari S, Shastri JG, et al
    Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2658.
    PubMed     Text format     Abstract available

  19. LEE KS, Lee K, Yun S, Moon S, et al
    Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2675.
    PubMed     Text format     Abstract available

  20. SCHIPMANN S, Molina ES, Frasch A, Stummer W, et al
    Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients.
    J Neurooncol. 2017 Nov 17. doi: 10.1007/s11060-017-2670.
    PubMed     Text format     Abstract available

  21. LIN AJ, Campian JL, Hui C, Rudra S, et al
    Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2668.
    PubMed     Text format     Abstract available

  22. PATEL S, Wang S, Snuderl M, Karajannis MA, et al
    Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2678.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  23. ESCHBACHER JM, Georges JF, Belykh E, Yazdanabadi MI, et al
    Immediate Label-Free Ex Vivo Evaluation of Human Brain Tumor Biopsies With Confocal Reflectance Microscopy.
    J Neuropathol Exp Neurol. 2017;76:1008-1022.
    PubMed     Text format     Abstract available

  24. YAO ZG, Li WH, Hua F, Cheng HX, et al
    LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1alpha Expression.
    J Neuropathol Exp Neurol. 2017;76:1000-1007.
    PubMed     Text format     Abstract available


    J Neurosurg

  25. MAO L, Whitehead CA, Paradiso L, Kaye AH, et al
    Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
    J Neurosurg. 2017 Nov 17:1-13. doi: 10.3171/2017.5.JNS17845.
    PubMed     Text format     Abstract available


    Neuro Oncol

  26. LAKS DR, Oses-Prieto JA, Alvarado AG, Nakashima J, et al
    A Molecular Cascade Modulates MAP1B and Confers Resistance to mTOR Inhibition in Human Glioblastoma.
    Neuro Oncol. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. NASSIRI F, Zadeh G, Aldape K
    IDH mutation testing in gliomas-where do we draw the line?
    Neuro Oncol. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format    


    Neuroradiology

  28. LIN Y, Xing Z, She D, Yang X, et al
    IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
    Neuroradiology. 2017 May 4. doi: 10.1007/s00234-017-1839.
    PubMed     Text format     Abstract available


    Pediatr Neurosurg

  29. GILBERT AR, Zaky W, Gokden M, Fuller CE, et al
    Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin.
    Pediatr Neurosurg. 2017 Nov 4. doi: 10.1159/000481513.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  30. NEUFELD Z, von Witt W, Lakatos D, Wang J, et al
    The role of Allee effect in modelling post resection recurrence of glioblastoma.
    PLoS Comput Biol. 2017;13:e1005818.
    PubMed     Text format     Abstract available


    PLoS One

  31. COROLLER TP, Bi WL, Huynh E, Abedalthagafi M, et al
    Radiographic prediction of meningioma grade by semantic and radiomic features.
    PLoS One. 2017;12:e0187908.
    PubMed     Text format     Abstract available

  32. HERMANSEN SK, Sorensen MD, Hansen A, Knudsen S, et al
    A 4-miRNA signature to predict survival in glioblastomas.
    PLoS One. 2017;12:e0188090.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  33. SUN T, Zhang Y, Power C, Alexander PM, et al
    Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201713328.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: